Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do antiphospholipid antibodies develop for a purpose?

Joan T Merrill1

  • 1Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. jtmmail@aol.com

Current Rheumatology Reports
|March 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adiposity-Associated Monocyte Costimulatory Programming in Rheumatoid Arthritis Identified by Single-Cell Transcriptomics.

medRxiv : the preprint server for health sciences·2026
Same author

Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026
Same author

"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Journal of clinical epidemiology·2026
Same author

Comparative Performance of LFA-REAL, SLEDAI, and BILAG for Detecting Clinically Meaningful Changes in Lupus Activity.

Arthritis care & research·2026
Same author

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
Same journal

Management of IgG4-Related Disease.

Current rheumatology reports·2026
See all related articles

Antiphospholipid antibodies, crucial for innate immunity, are beneficial for host defense. They only become harmful in susceptible individuals during adverse intravascular events, suggesting a protective role.

Area of Science:

  • Immunology
  • Autoimmunity

Background:

  • Antiphospholipid antibodies are implicated in antiphospholipid syndrome.
  • Their role in innate immunity is increasingly recognized.

Purpose of the Study:

  • To review evidence on the beneficial roles of antiphospholipid antibodies.
  • To explore the transition of these antibodies from protective to pathogenic.

Main Methods:

  • Literature review of studies on antiphospholipid antibodies and their functions.
  • Analysis of evidence linking natural autoantibodies to antiphospholipid syndrome.

Main Results:

  • Antiphospholipid antibodies originate from natural autoantibodies with beneficial functions.
  • These antibodies play key roles in the innate immune response.

Related Experiment Videos

  • Pathogenicity arises under specific adverse intravascular conditions in susceptible individuals.
  • Conclusions:

    • Antiphospholipid antibodies serve a protective purpose in host defense.
    • Their pathogenic potential is context-dependent, linked to specific intravascular events.